Sign in

CIK 0001231457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

GENELUX Corp

Sign in to watch
Ticker
GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 805-267-9889
Business address
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE, CA, 91361
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$155,693
in 6 filings

Net −$155,693. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-09-26 Szalay Aladar 10% owner Sale −9,600 $24.51 $235K 1,530,723
2023-09-26 Yu Yong VP, Clinical Trial Operations Exercise or conversion +5,200 $6.00 $31K 111,335
2023-09-26 Yu Yong VP, Clinical Trial Operations Sale −1,883 $22.54 $42K 109,452
2023-09-26 Yu Yong VP, Clinical Trial Operations Sale −1,114 $23.51 $26K 108,338
2023-09-26 Yu Yong VP, Clinical Trial Operations Sale −2,203 $24.46 $54K 106,135
2023-09-26 Yu Yong VP, Clinical Trial Operations Exercise or conversion · Stock Option (right to buy) −5,200 218,053
2023-09-25 Szalay Aladar 10% owner Sale −3,947 $24.82 $98K 1,569,039
2023-09-25 Szalay Aladar 10% owner Sale −5,511 $25.75 $142K 1,563,528
2023-09-25 Szalay Aladar 10% owner Sale −1,900 $26.60 $51K 1,561,628
2023-09-25 Szalay Aladar 10% owner Sale −1,100 $27.81 $31K 1,560,528
2023-09-22 Szalay Aladar 10% owner Sale −4,421 $26.88 $119K 1,577,607
2023-09-22 Szalay Aladar 10% owner Sale −4,621 $27.76 $128K 1,572,986
2023-09-21 Szalay Aladar 10% owner Sale −2,871 $27.89 $80K 1,586,706
2023-09-21 Szalay Aladar 10% owner Sale −4,678 $28.82 $135K 1,582,028
2023-09-20 Yu Yong VP, Clinical Trial Operations Exercise or conversion +6,000 $6.00 $36K 112,135
2023-09-20 Yu Yong VP, Clinical Trial Operations Sale −6,000 $27.96 $168K 106,135
2023-09-20 Yu Yong VP, Clinical Trial Operations Exercise or conversion · Stock Option (right to buy) −6,000 223,253
2023-09-20 Ryder Sean General Counsel Exercise or conversion +10,000 $6.00 $60K 10,572
2023-09-20 Ryder Sean General Counsel Sale −10,000 $30.00 $300K 572
2023-09-20 Ryder Sean General Counsel Exercise or conversion · Stock Option (right to buy) −10,000 140,000

Page 12 of 16 · 315 trades